Investment Counselors of Maryland’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
Sell
-189,104
Closed -$13.3M 214
2015
Q2
$13.3M Hold
189,104
0.62% 94
2015
Q1
$15M Sell
189,104
-38,000
-17% -$2.8M 0.71% 82
2014
Q4
$14.5M Sell
227,104
-79,875
-26% -$5.01M 0.7% 78
2014
Q3
$18.3M Sell
306,979
-44,603
-13% -$2.55M 0.91% 50
2014
Q2
$18.8M Sell
351,582
-3,518
-1% -$193K 0.81% 69
2014
Q1
$21.4M Sell
355,100
-31,500
-8% -$1.84M 0.91% 47
2013
Q4
$20.5M Sell
386,600
-10,200
-3% -$512K 0.84% 56
2013
Q3
$18.4M Buy
396,800
+10,350
+3% +$475K 0.78% 62
2013
Q2
$15.9M Buy
+386,450
New +$16.6M 0.7% 67

Other funds holding CRL

Investment Counselors of Maryland's CRL Position: Q3 2015 in Review

Investment Counselors of Maryland sold out of Charles River Laboratories (CRL) in Q3 2015, closing a stake of 189,104 shares — an estimated $13.3M sold.

Investment Counselors of Maryland first reported a position in CRL in Q2 2013 and held it in 9 quarters. The position peaked at $21.4M in Q1 2014. 258 funds tracked by Wall St. Rank hold CRL as of Q3 2015.

  • Investment Counselors of Maryland reported no remaining Charles River Laboratories position as of Q3 2015 after selling out during the quarter.
  • Investment Counselors of Maryland sold 189,104 Charles River Laboratories shares in Q3 2015, an estimated $13.3M.
  • Investment Counselors of Maryland first reported a position in Charles River Laboratories in Q2 2013 and held it in 9 quarters.
  • Investment Counselors of Maryland's Charles River Laboratories position peaked at $21.4M in Q1 2014.
  • 258 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2015.

Based on Investment Counselors of Maryland's 13F filing for Q3 2015, filed 3 Nov 2015.